A carregar...

Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer

OBJECTIVES: Up to 70% of endometrioid endometrial cancers carry PTEN gene deletions that can upregulate mTOR activity. Investigational mTOR kinase inhibitors may provide a novel therapeutic approach for these tumors. Using a xenograft tumor model of endometrial cancer, we assessed the activity of mT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Korets, Sharmilee Bansal, Musa, Fernanda, Curtin, John, Blank, Stephanie V., Schneider, Robert J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696930/
https://ncbi.nlm.nih.gov/pubmed/24316308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.11.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!